Research Article
Clinical Profile and Limitations in the Management of HBV Patients Attending Clinic at a District Hospital in Ghana
Table 1
Baseline characteristics of study participants.
| | Baseline characteristics | Chronic HBV () | Liver cirrhosis () | HCC () | value |
| | Median age (IQR) | 32 (27–39) | 45 (37–55) | 39 (29–46) | 0.001 | | Sex | | Male | 80 (35.0) | 36 (66.7) | 46 (86.8) | 0.001 | | Female | 147 (65.0) | 18 (33.3) | 7 (13.2) | | | HBV DNA IU/ML, median (IQR) | 1569 (167–4886) | 13,816 (2350-117,000) | 15,550 (1497-20,666) | 0.64 | | APRI score median (IQR) | 0.33 (0.22–0.5) | 3.07 (1.39–6.95) | 0.92 (0.71-1.12) | 0.001 | | ALT U/L median (IQR) | 27.2 (18.2–40) | 69 (38–131) | 68.9 (49.4-112.8) | 0.001 | | HBeAg | | Positive | 9 (4.62) | 0 (0) | 2 (3.77) | 0.28 | | Negative | 186 (95.38) | 53 (0) | 51 (96.23) | |
|
|
Not all patients could afford HBeAg testing; therefore, some values are not included. Not included are the following: chronic , liver , and . |
